美国精准癌症医学的“战略”发展。
'Strategic' development of precision cancer medicine in the United States.
机构信息
University of Chicago, Chicago, IL, USA.
出版信息
Mol Oncol. 2021 Jul;15(7):1747-1749. doi: 10.1002/1878-0261.13023. Epub 2021 Jun 24.
Abstract
The availability of advanced omics technologies has largely driven development of precision cancer medicine in the United States, but integration in routine cancer care has been challenging. Here, we consider some parameters that would enable a more coordinated, integrated, efficient, and equitable implementation of precision cancer medicine.
摘要
先进的组学技术的出现极大地推动了美国精准癌症医学的发展，但在常规癌症护理中的整合具有挑战性。在这里，我们考虑了一些参数，这些参数将使精准癌症医学的实施更加协调、综合、高效和公平。
相似文献
1
'Strategic' development of precision cancer medicine in the United States.
Mol Oncol. 2021 Jul;15(7):1747-1749. doi: 10.1002/1878-0261.13023. Epub 2021 Jun 24.
2
Clinical application of advanced multi-omics tumor profiling: Shaping precision oncology of the future.
Cancer Cell. 2022 Sep 12;40(9):920-938. doi: 10.1016/j.ccell.2022.08.011. Epub 2022 Sep 1.
3
The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Int J Mol Sci. 2019 Sep 26;20(19):4781. doi: 10.3390/ijms20194781.
4
Revolutionizing Precision Oncology through Collaborative Proteogenomics and Data Sharing.
Cell. 2018 Apr 19;173(3):535-539. doi: 10.1016/j.cell.2018.04.008.
5
A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs.
J Oncol Pract. 2017 Feb;13(2):e108-e119. doi: 10.1200/JOP.2016.011486. Epub 2016 Oct 31.
6
Contextual factors influencing the equitable implementation of precision medicine in routine cancer care in Belgium.
Eur J Public Health. 2024 Aug 1;34(4):624-631. doi: 10.1093/eurpub/ckae055.
7
Strategies For Clinical Implementation: Precision Oncology At Three Distinct Institutions.
Health Aff (Millwood). 2018 May;37(5):751-756. doi: 10.1377/hlthaff.2017.1575.
8
Accelerating cancer omics and precision oncology in health care and research: a Lancet Oncology Commission.
Lancet Oncol. 2023 Feb;24(2):123-125. doi: 10.1016/S1470-2045(23)00007-4.
9
Precision medicine in oncology: New practice models and roles for oncology pharmacists.
Am J Health Syst Pharm. 2016 Dec 1;73(23):1935-1942. doi: 10.2146/ajhp160211.
10
The road map of cancer precision medicine with the innovation of advanced cancer detection technology and personalized immunotherapy.
Jpn J Clin Oncol. 2019 Jul 1;49(7):596-603. doi: 10.1093/jjco/hyz073.
引用本文的文献
1
Diagnostic and prognostic role of microRNA-525 in different cancers: a systematic review and meta-analysis.
Transl Cancer Res. 2024 Aug 31;13(8):4301-4314. doi: 10.21037/tcr-24-383. Epub 2024 Aug 27.
2
The Porto European Cancer Research Summit 2021.
Mol Oncol. 2021 Oct;15(10):2507-2543. doi: 10.1002/1878-0261.13078. Epub 2021 Sep 13.
本文引用的文献
1
Clinical Cancer Advances 2021: ASCO's Report on Progress Against Cancer.
J Clin Oncol. 2021 Apr 1;39(10):1165-1184. doi: 10.1200/JCO.20.03420. Epub 2021 Feb 2.
Zotero 插件